CONMED CNMD Orthopedic Surgery — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's orthopedic surgery — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CONMED's orthopedic surgery — net sales?
- CONMED (CNMD) reported orthopedic surgery — net sales of $147.66M in Q1 2026.
- How has CONMED's orthopedic surgery — net sales changed year-over-year?
- CONMED's orthopedic surgery — net sales increased by 6.8% year-over-year, from $138.29M to $147.66M.
- What is the long-term trend for CONMED's orthopedic surgery — net sales?
- Over 4 years (2021 to 2025), CONMED's orthopedic surgery — net sales has grown at a 7.0% compound annual growth rate (CAGR), from $438.43M to $574.6M.
- What does orthopedic surgery — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices, instruments, and implants specifically designed for orthopedic surgical procedures. It serves as a key indicator of the company's market penetration and demand within the sports medicine and musculoskeletal surgery sectors. Tracking this figure allows investors to evaluate the growth trajectory and competitive performance of the orthopedic product portfolio relative to broader surgical market trends.